Plasma ANGPTL8 Levels and Risk for Secondary Cardiovascular Events in Japanese Patients With Stable Coronary Artery Disease Receiving Statin Therapy.
Jun MorinagaKosuke KashiwabaraDaisuke TorigoeYusuke OkadomeKenichi AizawaKohei UemuraAi KurashimaEiji MatsunagaHirotaka FukamiHaruki HoriguchiMichio SatoTaichi SugizakiKeishi MiyataTsuyoshi KadomatsuMasashi MukoyamaKatsumi MiyauchiSeiji HokimotoYoshihiro FukumotoTakafumi HiroKiyoshi HibiYoshihisa NakagawaIchiro SakumaYukio OzakiHiroshi IwataSatoshi IimuroHiroyuki DaidaHiroaki ShimokawaTakeshi KimuraMasunori MatsuzakiYasushi SaitoYutaka MatsuyamaRyozo NagaiYuichi OikePublished in: Arteriosclerosis, thrombosis, and vascular biology (2023)
Monitoring ANGPTL8 levels over time might be useful to assess residual risk of cardiovascular secondary events in patients with cardiovascular disease undergoing statin therapy.